| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief R &Qa Officer | Chief R &Qa Officer
1 company
Clark Mitchall G. is an EVP &Chief R &Qa Officer at Atara Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2016 | ATRA Atara Biotherapeutics, Inc. | Chief R &Qa Officer | Sale+OE | 4,153 | $15.35 | $63,748.55 | -4.9% | |
| Nov 16, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief R &Qa Officer | Sale+OE | 4,153 | $31.67 | $131,525.51 | -10.7% | |
| Aug 17, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief R &Qa Officer | Sale+OE | 7,829 | $46.19 | $361,621.51 | -18.7% |